Oxidative stress has a role in malignant transformation in Barrett's oesophagus

International Journal of Cancer

Volumn 102, Issue 6, 2002, Pages 551-555

  Sihvo, Eero I T ^a   Salminen, Jukka T ^a   Rantanen, Tuomo K ^b   Rämö, O Juhani ^a   Ahotupa, Markku ^c   Färkkilä, Martti ^a   Auvinen, Merja I ^a   Salo, Jarmo A ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TURKU UNIVERSITY   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Barrett's oesophagus; Malignant transformation; Oxidative stress

Indexed keywords

GLUTATHIONE; MYELOPEROXIDASE; SCAVENGER; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DNA ADDUCT; ENZYME ACTIVITY; ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; DNA ADDUCTS; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROESOPHAGEAL REFLUX; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEROXIDASE; SUPEROXIDE DISMUTASE;

EID: 0037146760     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10755     Document Type: Article

References (46)

1. Blot WJ, Deveasa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
2. Sihvo EIT, Salminen JT, Rämö OJ, Salo JA. The epidemiology of oesophageal adenocarcinoma: Has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma? Scand J Gastroenterol 2000;35:1082-6.
3. Chen X, Yang CY. Esophageal adenocarcinoma: A review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 2001;22:1119-29.
4. Oh TY, Lee JS, Ahn BO, Cho H, Kim WB, Kim YB, Surh YJ, Cho SW, Hahm KB. Oxidative damages are critical in pathogenesis of reflux esophagitis: Implication of antioxidants in its treatment. Free Radic Biol Med 2001;30:905-15.
5. Collins RH, Feldman M, Fordtran JS. Colon cancer, dysplasia and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 1987;316:1654-8.
6. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, Kasai H. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 1994;54:3171-2.
7. Holzinger F, Z'graggen K, Büchler MW. Mechanisms of biliary carcinogenesis: A pathogenetic multi-stage cascade towards cholangiocarcinoma. Ann Oncol 1999;10:S122-6.
8. Farhadi A, Fields J, Banan A, Keshavarzian A. Reactive oxygen species: Are they involved in the pathogenesis of GERD, Barrett's esophagus and the latter's progression toward esophageal cancer? AJG 2002;97:22-6.
9. Li D, Wang M, Dhingra K, Hittelman WN. Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology. Cancer Res 1996;56:287-93.
10. Lee BM, Jang JJ, Kim HS. Benzo[a]pyrene-epoxide-I-DNA and oxidative DNA adducts associated with gastric adenocarcinoma. Cancer Lett 1998;125:61-8.
11. Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, Chiao P, Li D. DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. Cancer Res 1998;58:38-41.
12. Poirier MC. DNA adducts as exposure biomarkers and indicators of cancer risk. Environ Health Perspect 1997;105:907-12.
13. Floyd RA. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 1990;11:1447-50.
14. Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 1984;12:2137-45.
15. Nestmann ER, Bryant DW, Carr CJ. Toxicological significance of DNA adducts: Summary of discussions with an expert panel. Regul Toxicol Pharmacol 1996;24:9-18.
16. Ogino K, Oka S, Okazaki Y, Takemoto T. Gastric mucosal protection and superoxide dismutase. J Clin Gastroenterol 1988;10(Suppl):S129-32.
17. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a coordinately regulated defence against oxidative stress. Free Radic Res 1999;31:273-300.
18. Peters WHM, Roelofs HMJ, Hectors MPC, Nagengast FM, Jansen JB. Glutathione and glutathione s-transferases in Barrett's epithelium. Br J Cancer 1993;67:1413-7.
19. Wetscher GJ, Hinder RA, Bagchi D, Hinder PR, Bagchi M, Perdikis G, McGinn T. Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 1995;170:552-6.
20. Olyaee M, Sontag S, Salman W, Schnell T, Mobarhan S, Eiznhamer D, Keshavarzian A. Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus. Gut 1995;37:168-73.
21. Klebanoff SJ. Myeloperoxidase. Proc Assoc Am Physicians 1999;111:383-9.
22. Petruska JM, Mosebrook DR, Jakab GJ, Trush MA. Myeloperoxidase-enhanced formation of (±)-trans-7,8-dihydroxy-7,8-dihydrob-ezopyrene-DNA adducts in the lung tissue in vitro: A role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis 1992;13:1075-81.
23. Savary M, Miller G. The Esophagus. Handbook and Atlas of Endoscopy. Solothurn, Switzerland: Gassmann AG;1978:135-9.
24. Richardson JD, Kuhns JG, Richardson RL, Polk HC Jr. Properly conducted fundoplication reverses histologic evidence of esophagitis. Ann Surg 1983;197:763-70.
25. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
26. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983;132:345-52.
27. Laihia JK, Jansen CT, Ahotupa M. Lucigenin and linoleate enhanced chemiluminescent assay for superoxide dismutase activity. Free Radic Biol Med 1993;14:457-61.
28. Saville B. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 1985;83:670-2.
29. Gupta RC. Non-random binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci USA 1984;81:6943-7.
30. Hemminki K, Widlak P, Hou S-M. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro. Carcinogenesis 1995;16:1661-4.
31. DeMeester SR, DeMeester TR. Columnar mucosa and intestinal metaplasia of the esophagus: Fifty years of controversy. Ann Surg 2000;231:303-21.
32. Wu TT, Watanabe T, Heitmiller R, Zahurak M, Forastiere AA, Hamilton SR. Genetic alterations in Barrett's esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol 1998;153:287-94.
33. Wijnhoven BPL, Tilanus HW, Dinjens WNM. Molecular biology of Barrett's adenocarcinoma. Ann Surg 2001;233:322-37.
34. Lagergren J, Bergström R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
35. Williams JA. Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: Why molecular epidemiologists should think about enzyme expression. Carcinogenesis 2001;22:209-14.
36. Schmid K, Nair J, Winde G, Velic I, Bartsch H. Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients. Int J Caner 2000;87:1-4.
37. Li D, Zhang W, Sahin AA, Hittelman WN. DNA adducts in normal tissue adjacent to breast cancer. Cancer Detect Prev 1999;23:454-62.
38. De Flora S, Izzotti A, Randerath K, Randerath E, Bartsch H, Nair J, Balansky R, van Schooten F, Degan P, Fronza G, Walsh D, Lewtas J. DNA adducts and chronic degenerative diseases. Pathogenetic relevance and implications in preventive medicine. Mutat Res 1996;366:197-238.
39. Ikebuchi M, Kashiwagi A, Asahina T, Tanaka Y, Takanagi Y, Nishio Y, Hidaka H, Kikkawa R, Shigeta Y. Effect of medium pH on glutathione redox cycle in cultured human umbilical vein endothelial cells. Metabolism 1993;42:1121-6.
40. Korenaga D, Takesue F, Kido K, Yasuda M, Inutsuka S, Honda M, Nagahama S. Impaired antioxidant defense system of colonic tissue and cancer development in dextran sulfate sodium-induced colitis in mice. J Surg Res 2002;102:144-9.
41. Harris CA, Derbin KS, Hunte-McDonough B, Krauss MR, Chen KT, Smith DM, Epstein LB. Manganese superoxide dismutase is induced by IFN-γ in multiple cell lines. Synergistic induction by IFN-γ tumor necrosis factor or IL-1. J Immunol 1991;147:149-54.
42. Chung-man HJ, Zheng S, Comhair SA, Farver C, Erzurum SC. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res 2001;61:8578-85.
43. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer 1996;32A:30-8.
44. Oliva MR, Ripoll F, Muniz P, Iradi A, Trullenque R, Valls V, Drehmer E, Saez GT. Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community. Mol Carcinog 1997;18:232-43.
45. Janssen AM, Bosman CB, van Duijn W, Oostendorp-van de Ruit MM, Kubben FJ, Griffioen G, Lamers CB, van Krieken JH, van de Velde CJ, Verspaget HW. Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin Cancer Res. 2000;6:3183-92.
46. Terry P, Lagergren J, Ye W, Nyren O, Wolk A. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer 2000;87:750-4.